Skip to main navigation
Skip to search
Skip to main content
Oregon Health & Science University Home
Help & FAQ
Home
Profiles
Research units
Core Facilities
Publications
Search by expertise, name or affiliation
Adjuvant systemic therapy for renal cell carcinoma
Christopher W. Ryan
Knight Cancer Institute
Research output
:
Chapter in Book/Report/Conference proceeding
›
Chapter
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Adjuvant systemic therapy for renal cell carcinoma'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Renal Cell Carcinoma
100%
Nephrectomy
68%
Cancer Vaccines
42%
Optimism
41%
Disease Management
34%
Standard of Care
33%
Interferons
31%
Interleukin-2
30%
Vascular Endothelial Growth Factor A
29%
Observation
24%
Placebos
23%
Carcinoma
22%
Survival
19%
Kidney
18%
Therapeutics
17%
Neoplasms
11%